Literature DB >> 19716348

Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study.

Mandeep Bhargava1, Luigi Di Biase, Prasant Mohanty, Subramanyam Prasad, David O Martin, Michelle Williams-Andrews, Oussama M Wazni, J David Burkhardt, Jennifer E Cummings, Yaariv Khaykin, Atul Verma, Steven Hao, Salwa Beheiry, Richard Hongo, Antonio Rossillo, Antonio Raviele, Aldo Bonso, Sakis Themistoclakis, Kelly Stewart, Walid I Saliba, Robert A Schweikert, Andrea Natale.   

Abstract

BACKGROUND/
OBJECTIVE: The purpose of this prospective multicenter study was to compare results of catheter ablation in patients with paroxysmal atrial fibrillation (PAF) and those with nonparoxysmal atrial fibrillation (NPAF). The impact and the role of repeat catheter ablation were assessed in patients with recurrence. METHODS/
RESULTS: One thousand four hundred four patients underwent catheter ablation for atrial fibrillation (AF) performed by 12 operators at four institutions using a single technique guided by intracardiac echocardiography. Of these patients, 728 had PAF and 676 had NPAF. Among the NPAF patients, 293 had persistent AF and 383 had long-standing persistent AF. Patients with NPAF had a higher incidence of hypertension and/or structural heart disease (64.8% vs 48.5%, P = .003) and a lower mean left ventricular ejection fraction (53.3% +/- 8.7% vs 55.7 +/- 6.5%, P <.001). All patients underwent antral isolation of all four pulmonary veins and the superior vena cava. At mean follow-up of 57 +/- 17 months, 565 of 728 patients with PAF and 454 of 676 patients with NPAF (77.6% vs 67.2%, P <.001) had freedom from AF after a single ablation procedure. For arrhythmia recurrences, 74.2% (121/163) patients with PAF and 74.8% (166/222) with NPAF underwent repeat ablation, after which 92.4% patients with PAF and 84.0% patients with NPAF remained free from AF.
CONCLUSION: Pulmonary vein antrum isolation guided by intracardiac echocardiography results in significant freedom from AF, even when performed by multiple operators in different centers. At least moderate efficacy can be achieved in patients with NPAF, although the success rate is lower than in patients with PAF. Considerably higher success can be achieved in both groups with repeat ablation.

Entities:  

Mesh:

Year:  2009        PMID: 19716348     DOI: 10.1016/j.hrthm.2009.06.014

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  73 in total

Review 1.  Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation: systematic review and meta-analysis.

Authors:  Kueiyu Joshua Lin; Soung Ick Cho; Nidhish Tiwari; Michael Bergman; Jorge R Kizer; Eugen C Palma; Cynthia C Taub
Journal:  J Interv Card Electrophysiol       Date:  2013-12-19       Impact factor: 1.900

2.  The "battle" against paroxysmal atrial fibrillation: is there a role for left atrial mechanical dyssynchrony evaluated by speckle tracking?

Authors:  Luigi Di Biase; Pasquale Santangeli; J David Burkhardt; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2013-12-10       Impact factor: 1.900

3.  Atrial fibrillation: permanent isolation of the PV antrum begets cure.

Authors:  Pasquale Santangeli; Andrea Natale
Journal:  Nat Rev Cardiol       Date:  2011-03-01       Impact factor: 32.419

Review 4.  Myocardial Ischemia as a Genuine Cause Responsible for the Organization and "Fertilization" of Conflictogenic Atrial Fibrillation:New Conceptual Insights Into Arrhythmogenicity.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2013-04-06

5.  Occult obstructive sleep apnea and clinical outcomes of radiofrequency catheter ablation in patients with atrial fibrillation.

Authors:  Peter M Farrehi; Louise M O'Brien; Hatice Duygu Bas; Kazim Baser; Krit Jongnarangsin; Rakesh Latchamsetty; Hamid Ghanbari; Thomas Crawford; Frank Bogun; Eric Good; Frank Pelosi; Aman Chugh; Fred Morady; Hakan Oral
Journal:  J Interv Card Electrophysiol       Date:  2015-06-03       Impact factor: 1.900

6.  Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation.

Authors:  Khang-Li Looi; Parag Gajendragadkar; Tamer Taha; Maros Elsik; Elizabeth Scully; Patrick Heck; Simon Fynn; Munmohan Virdee; David Begley
Journal:  J Interv Card Electrophysiol       Date:  2012-10-25       Impact factor: 1.900

7.  Left atrial appendage volume as a new predictor of atrial fibrillation recurrence after catheter ablation.

Authors:  Pedro Pinto Teixeira; Mário Martins Oliveira; Ruben Ramos; Pedro Rio; Pedro Silva Cunha; Ana Sofia Delgado; Ricardo Pimenta; Rui Cruz Ferreira
Journal:  J Interv Card Electrophysiol       Date:  2017-05-31       Impact factor: 1.900

8.  Novel association of polymorphic genetic variants with predictors of outcome of catheter ablation in atrial fibrillation: new directions from a prospective study (DECAF).

Authors:  Sanghamitra Mohanty; Amelia W Hall; Prasant Mohanty; Sameer Prakash; Chintan Trivedi; Luigi Di Biase; Pasquale Santangeli; Rong Bai; J David Burkhardt; G Joseph Gallinghouse; Rodney Horton; Javier E Sanchez; Patrick M Hranitzky; Amin Al-Ahmad; Vishwanath R Iyer; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2016-01       Impact factor: 1.900

Review 9.  Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation.

Authors:  Jeffrey W Holmes; Zachary Laksman; Lior Gepstein
Journal:  Prog Biophys Mol Biol       Date:  2015-11-23       Impact factor: 3.667

10.  Pulmonary venous isolation by antral ablation with a large cryoballoon for treatment of paroxysmal and persistent atrial fibrillation: medium-term outcomes and non-randomised comparison with pulmonary venous isolation by radiofrequency ablation.

Authors:  Pipin Kojodjojo; Mark D O'Neill; Phang Boon Lim; Louisa Malcolm-Lawes; Zachary I Whinnett; Tushar V Salukhe; Nicholas W Linton; David Lefroy; Anthony Mason; Ian Wright; Nicholas S Peters; Prapa Kanagaratnam; D Wyn Davies
Journal:  Heart       Date:  2010-09       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.